NYU Langone Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).

1,164 total trials 197 currently recruiting 741 completed early-phase tilt top decile by trial count

NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.

NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.

Top-decile sponsor footprint

NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,164 total, page 12 of 24

COMPLETED Phase 4

Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA)

NCT03913091

COMPLETED NA

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial

NCT03681119

COMPLETED NA

Research Exploring Sleep Education & Technology

NCT03489460

TERMINATED NA

Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

NCT03717532

COMPLETED NA

Preventing Smoking Relapse After Total Joint Replacement Surgery

NCT03673228

COMPLETED NA

PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy

NCT03635866

COMPLETED

Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD

NCT03389698

COMPLETED NA

i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management

NCT03652389

COMPLETED NA

Integrated Community-Clinical Linkage Model to Promote Weight Loss Among South Asians With Pre-Diabetes

NCT03188094

COMPLETED NA

Walking or High Intensity Exercise for Anxiety

NCT03819426

COMPLETED

A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment

NCT03611335

COMPLETED

Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples

NCT03663400

COMPLETED NA

Enhanced Quality in Primary Care for Elders With Diabetes and Dementia

NCT03723707

COMPLETED Phase 4

Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

NCT03693404

COMPLETED NA

Training in the 21st Century: Using Virtual Role-Plays to Improve Nurse Communication for Medication Adherence

NCT03599050

COMPLETED NA

Patient Satisfaction With Postoperative Communication Modality

NCT04338425

COMPLETED NA

Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A

NCT03519347

COMPLETED NA

Reversing Diabetic Peripheral Neuropathy Through Exercise

NCT03686423

COMPLETED

The Sleep Amyloid, Slow WAve Race and Ethnicity Study

NCT03814603

COMPLETED NA

Introductory Clinical Trial for Measuring Patients Before, During, and After an Electrophysiology (EP) Procedure With a Novel, Body-Worn Sensor

NCT03657134

TERMINATED NA

Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

NCT03560609

TERMINATED NA

Equine Facilitated CBT Group Therapy for Youth Anxiety

NCT03838835

COMPLETED

Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial

NCT03581006

COMPLETED NA

Upper Extremity Post-op Splints: Do They Improve Post-operative Pain?

NCT03891966

COMPLETED NA

Extending Sleep to Reverse Metabolic Syndrome in Middle-aged Adults: Acceptability and Feasibility of a Sleep Intervention

NCT03599388

COMPLETED Phase 2

Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria

NCT03663855

COMPLETED NA

Effect of Intra-procedure Music on Anxiety

NCT03665662

COMPLETED NA

Effect of Hydroxycitrate on Urine Chemistry

NCT03348228

COMPLETED NA

Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple Sclerosis

NCT03658668

COMPLETED

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

NCT03714191

COMPLETED NA

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

NCT03672838

COMPLETED NA

Promoting Success for Pre-K Teachers, Families and Children

NCT03524105

COMPLETED

Testing the Decoy Effect to Increase Tobacco Treatment Uptake

NCT04200157

COMPLETED NA

The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages

NCT04971317

COMPLETED NA

Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City

NCT03397511

COMPLETED NA

Deep-Learning for Automatic Polyp Detection During Colonoscopy

NCT03637712

TERMINATED Phase 2

A Futility Trial of Sirolimus in Multiple System Atrophy

NCT03589976

COMPLETED NA

Dementia Symptom Management at Home Program

NCT03255967

COMPLETED NA

Patient-Centered Cancer Prevention In Chinese Americans

NCT03340454

COMPLETED NA

Methods to Improve Preventative Care Uptake

NCT03685981

COMPLETED NA

Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission

NCT03683797

TERMINATED NA

The Dementia Symptom Management at Home Program Hospice Edition

NCT03352791

TERMINATED Phase 2

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

NCT03599362

COMPLETED NA

BMAC & Allograft vs BMP-2

NCT02924571

COMPLETED NA

Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement

NCT03601754

COMPLETED NA

Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI

NCT03564496

TERMINATED Phase 1

Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma

NCT03580382

TERMINATED NA

Understanding the Role of Sleep in Complicated Grief

NCT03533465

TERMINATED

Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis (MS)

NCT03723356

COMPLETED Phase 4

Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

NCT03606109

← Previous Page 12 of 24 Next →

Phase Distribution

PhaseTrial count
Phase 1 99
Phase 2 132
Phase 3 28
Phase 4 95

What is open in the NYU Langone Health pipeline

197 recruiting of 1,164 indexed (17% open); 741 completed (64%).

Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

NYU Langone Health: open-pipeline peers nationwide

Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 15%16%17%18%19% Total trials Recruiting share NYU Langone HealthUniversity of Alabama at BirminghamWake Forest University Health SciencesEmory UniversityNorthwestern UniversityCSL BehringPenn State UniversityUniversity of HawaiiUniversity of Utah
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,164 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this NYU Langone Health page

1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.

  • 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.